Michele Comberlato

812 total citations
24 papers, 396 citations indexed

About

Michele Comberlato is a scholar working on Surgery, Genetics and Epidemiology. According to data from OpenAlex, Michele Comberlato has authored 24 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 12 papers in Genetics and 11 papers in Epidemiology. Recurrent topics in Michele Comberlato's work include Inflammatory Bowel Disease (11 papers), Microscopic Colitis (11 papers) and Helicobacter pylori-related gastroenterology studies (5 papers). Michele Comberlato is often cited by papers focused on Inflammatory Bowel Disease (11 papers), Microscopic Colitis (11 papers) and Helicobacter pylori-related gastroenterology studies (5 papers). Michele Comberlato collaborates with scholars based in Italy, United States and Canada. Michele Comberlato's co-authors include G Dobrilla, Marco Daperno, R. D’Incà, Livia Biancone, Ambrogio Orlando, Fernando Rizzello, Fabrizio Bossa, R. Cosintino, R. Mangiarotti and Alfredo Papa and has published in prestigious journals such as The American Journal of Gastroenterology, Gastrointestinal Endoscopy and Journal of Clinical Gastroenterology.

In The Last Decade

Michele Comberlato

23 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michele Comberlato Italy 8 202 195 149 126 94 24 396
C Sategna-Guidetti Italy 12 175 0.9× 178 0.9× 200 1.3× 196 1.6× 49 0.5× 23 451
Cécile Poupardin France 8 111 0.5× 77 0.4× 96 0.6× 55 0.4× 39 0.4× 12 243
W Kruis Germany 6 168 0.8× 117 0.6× 129 0.9× 41 0.3× 56 0.6× 18 343
N. B. Gubergrits Ukraine 7 209 1.0× 245 1.3× 201 1.3× 43 0.3× 137 1.5× 52 441
David B. Sachar United States 7 271 1.3× 218 1.1× 213 1.4× 59 0.5× 43 0.5× 9 402
M E McAlindon United Kingdom 6 98 0.5× 210 1.1× 70 0.5× 164 1.3× 34 0.4× 23 336
Rupert Ransford United Kingdom 4 155 0.8× 133 0.7× 123 0.8× 62 0.5× 26 0.3× 8 315
Purushothaman Premchand United Kingdom 6 199 1.0× 97 0.5× 165 1.1× 40 0.3× 17 0.2× 11 319
R Schiöler Sweden 6 302 1.5× 149 0.8× 276 1.9× 67 0.5× 31 0.3× 7 373
Marc S. Piper United States 7 29 0.1× 63 0.3× 70 0.5× 33 0.3× 84 0.9× 28 222

Countries citing papers authored by Michele Comberlato

Since Specialization
Citations

This map shows the geographic impact of Michele Comberlato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Comberlato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Comberlato more than expected).

Fields of papers citing papers by Michele Comberlato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Comberlato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Comberlato. The network helps show where Michele Comberlato may publish in the future.

Co-authorship network of co-authors of Michele Comberlato

This figure shows the co-authorship network connecting the top 25 collaborators of Michele Comberlato. A scholar is included among the top collaborators of Michele Comberlato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Comberlato. Michele Comberlato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bevilacqua, Nazario, Roberto Gabbiadini, Cristina Bezzio, et al.. (2024). P535 Effectiveness of upadacitinib in patients with Ulcerative Colitis: a real-life, multicenter, Italian report. Journal of Crohn s and Colitis. 18(Supplement_1). i1045–i1046. 1 indexed citations
2.
Gionchetti, Paolo, Fernando Rizzello, Vito Annese, et al.. (2017). Use of corticosteroids and immunosuppressive drugs in inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease. Digestive and Liver Disease. 49(6). 604–617. 44 indexed citations
3.
Daperno, Marco, Aurora Bortoli, Anna Kohn, et al.. (2017). Patient and physician views on the quality of care for inflammatory bowel disease after one-year follow-up: Results from SOLUTION-2, a prospective IG-IBD study. Digestive and Liver Disease. 49(9). 997–1002. 7 indexed citations
4.
Daperno, Marco, Michele Comberlato, Fabrizio Bossa, et al.. (2016). Training Programs on Endoscopic Scoring Systems for Inflammatory Bowel Disease Lead to a Significant Increase in Interobserver Agreement Among Community Gastroenterologists. Journal of Crohn s and Colitis. 11(5). jjw181–jjw181. 44 indexed citations
5.
Daperno, Marco, Michele Comberlato, Fabrizio Bossa, et al.. (2014). P452 Increasing interobserver agreement on IBD endoscopic scoring systems: results from the IGIBDEndo educational program. Journal of Crohn s and Colitis. 8. S254–S255. 5 indexed citations
6.
Daperno, Marco, Michele Comberlato, Fabrizio Bossa, et al.. (2014). Inter-observer agreement in endoscopic scoring systems: Preliminary report of an ongoing study from the Italian Group for Inflammatory Bowel Disease (IG-IBD). Digestive and Liver Disease. 46(11). 969–973. 87 indexed citations
7.
Bortoli, Aurora, Marco Daperno, Anna Kohn, et al.. (2014). Patient and physician views on the quality of care in inflammatory bowel disease: Results from SOLUTION-1, a prospective IG-IBD study. Journal of Crohn s and Colitis. 8(12). 1642–1652. 25 indexed citations
8.
Daperno, Marco, Michele Comberlato, Fabrizio Bossa, et al.. (2014). PC.01.8 INCREASING INTEROBSERVER AGREEMENT ON IBD ENDOSCOPIC SCORING SYSTEMS: RESULTS FROM THE IGIBDENDO EDUCATIONAL PROGRAM. Digestive and Liver Disease. 46. S4–S4. 3 indexed citations
9.
Daperno, Marco, Michele Comberlato, Fabrizio Bossa, et al.. (2012). OC.12.1 INTEROBSERVER AGREEMENT IN IBD SCORES REQUIRES EXPERTISE AND EDUCATION: PRELIMINARY RESULTS FROM AN ONGOING IG-IBD STUDY. Digestive and Liver Disease. 44. S80–S81. 5 indexed citations
10.
Danese, Silvio, Filippo Mocciaro, Luisa Guidi, et al.. (2008). OC3.11.4 SUCCESSFUL INDUCTION OF CLINICAL RESPONSE AND REMISSION WITH CERTOLIZUMAB PEGOL CROHN'S DISEASE PATIENTS: A MULTI-CENTER EXPERIENCE OF COMPASSIONATE USE. Digestive and Liver Disease. 40. S69–S69. 1 indexed citations
11.
Piazzi, Luigi, Martina Felder, Michele Comberlato, et al.. (2007). Extracorporeal shock wave lithotripsy for clearance of refractory bile duct stones. Digestive and Liver Disease. 39(3). 267–272. 30 indexed citations
12.
Benvenuti, Stefano, Luigi Piazzi, Michele Comberlato, et al.. (2006). Prevention of post-ERCP pancreatitis with somatostatin versus gabexate mesylate: A randomized placebo controlled multicenter study. Digestive and Liver Disease. 38. S15–S15. 14 indexed citations
13.
Benvenuti, Stefano, et al.. (2006). Prevention of Post-ERCP Pancreatitis with Somatostatin Versus Gabexate Mesilate: A Randomized Placebo Controlled Multicenter Study. Gastrointestinal Endoscopy. 63(5). AB309–AB309. 5 indexed citations
14.
Piazzi, Luigi, Paige E. Farris, Michele Comberlato, et al.. (2002). 24 P Clearance of refractory bile duct stones with extracorporeal shock-wave lithotripsy (ESWL). Digestive and Liver Disease. 34. A124–A124. 1 indexed citations
15.
Frieri, Giuseppe, M.T. Pimpo, Giancarlo Palumbo, et al.. (2000). Anastomotic configuration and mucosal 5-aminosalicylic acid (5-ASA) concentrations in patients with crohn's disease: a GISC study. The American Journal of Gastroenterology. 95(6). 1486–1490. 15 indexed citations
16.
Dobrilla, G, et al.. (1996). [Diet and drugs in the therapy of nonorganic dyspepsia: the hypothesis and factual data].. PubMed. 42(2). 71–82. 1 indexed citations
17.
Dobrilla, G, et al.. (1991). Antisecretory agents, peptic secretion and serum pepsinogen in man.. PubMed. 23(2). 100–6. 2 indexed citations
18.
Dobrilla, G, et al.. (1989). Drug Treatment of Functional Dyspepsia. Journal of Clinical Gastroenterology. 11(2). 169–177. 86 indexed citations
19.
Dobrilla, G, et al.. (1988). Pirenzepine and upper gastrointestinal tract motility in man.. PubMed. 35(2). 51–3. 6 indexed citations
20.
Dobrilla, G, et al.. (1983). Pirenzepine and exocrine secretions: a selective agent for gastric glands?. PubMed. 30(6). 246–8. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C Sategna-Guidetti Breakdown of academic impact, for papers by Cécile Poupardin Breakdown of academic impact, for papers by W Kruis Breakdown of academic impact, for papers by N. B. Gubergrits Breakdown of academic impact, for papers by David B. Sachar Breakdown of academic impact, for papers by M E McAlindon Breakdown of academic impact, for papers by Rupert Ransford Breakdown of academic impact, for papers by Purushothaman Premchand Breakdown of academic impact, for papers by R Schiöler Breakdown of academic impact, for papers by Marc S. Piper
Rankless by CCL
2026